Standout Papers

Development of realistic high-resolution whole-body voxel models of Japanese adult males and fe... 2003 2026 2010 2018 1.6k
  1. Development of realistic high-resolution whole-body voxel models of Japanese adult males and females of average height and weight, and application of models to radio-frequency electromagnetic-field dosimetry (2003)
    Tomoaki Nagaoka, Soichi Watanabe et al. Physics in Medicine and Biology
  2. Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases (2006)
    Hidefumi Aoyama, Hiroki Shirato et al. JAMA

Citation Impact

Citing Papers

Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
2010 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
2009 Standout
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
2015
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
2012
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer
2014
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
2020
Adjuvant Whole Brain Radiotherapy: Strong Emotions Decide But Rational Studies Are Needed
2008
Idiopathic pulmonary fibrosis
2017 Standout
A view on drug resistance in cancer
2019 StandoutNature
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Hepatocellular carcinoma
2018 Standout
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
In-situ electric field and current density in Japanese male and female models for uniform magnetic field exposures
2009
Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncology Group Randomized Trials 0212 and 0214
2013
Systemic Collateral Supply in Patients with Chronic Thromboembolic and Primary Pulmonary Hypertension: Assessment with Multi–Detector Row Helical CT Angiography
2005
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
2011
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
2014 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Liver-Directed Radiotherapy for Hepatocellular Carcinoma
2016
Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: Mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05)
2006
Leukoencephalopathy after whole‐brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer
2012
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
The oligometastatic state—separating truth from wishful thinking
2014
The Evolving Landscape of Brain Metastasis
2018
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline
2012
Dosimetric Evaluation of Heterogeneity Corrections for RTOG 0236: Stereotactic Body Radiotherapy of Inoperable Stage I-II Non–Small-Cell Lung Cancer
2009
Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis
2015
Brain metastases: current management and new developments
2008
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
2014
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review
2015
Why avoid the hippocampus? A comprehensive review
2010
Printing ferromagnetic domains for untethered fast-transforming soft materials
2018 StandoutNature
Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: Results and toxicity
2006
Acute exacerbations of interstitial lung diseases
2010
Case 21-2013
2013
Development of the female voxel phantom, NAOMI, and its application to calculations of induced current densities and electric fields from applied low frequency magnetic and electric fields
2005
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
2013 Standout
A PILOT STUDY OF NEUROCOGNITIVE FUNCTION IN PATIENTS WITH ONE TO THREE NEW BRAIN METASTASES INITIALLY TREATED WITH STEREOTACTIC RADIOSURGERY ALONE
2007
Radiation Dose–Volume Effects in the Heart
2010
DIFFERENT BASIC DOSIMETRIC QUANTITIES FOR THE CHARACTERIZATION OF EXPOSURE TO LOW-FREQUENCY ELECTRIC AND MAGNETIC FIELDS AND THE IMPLICATION FOR PRACTICAL EXPOSURE CONDITIONS AND GUIDELINES
2007
Daily Alignment Results of In-Room Computed Tomography–Guided Stereotactic Body Radiation Therapy for Lung Cancer
2010
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
The value of 4-month neurocognitive function as an endpoint in brain metastases trials
2014
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
2015
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
2008
Idiopathic pulmonary fibrosis
2011 Standout
Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting
2017
Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial
2020
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
2012
Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma
2019
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
2021
Stereotactic Radiosurgery of the Postoperative Resection Cavity for Brain Metastases
2007
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Multiscale photoacoustic microscopy and computed tomography
2009 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance
2010
Hepatocellular carcinoma
2022 Standout
Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability
2013
Salvage surgery after high-dose radiotherapy
2017
Development of pregnant female, hybrid voxel-mathematical models and their application to the dosimetry of applied magnetic and electric fields at 50 Hz
2006
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
2012 Standout
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases
2014
Brain Metastases from Thyroid Carcinoma: A Retrospective Study of 21 Patients
2013
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage
2017
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
2017
Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)
2012
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
2014
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
2012
On the injectivity of the circular Radon transform
2005
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
2017
Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis
2019
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Diagnosis and Treatment of mela-noma Brain Metastasis: A Literature Review
2009
Influence of .BETA.-Adrenoceptor Blockade on the Myocardial Accumulation of Fatty Acid Tracer and Its Intracellular Metabolism in the Heart After Ischemia-Reperfusion Injury
2006
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes
2021
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Spatially selective remote magnetic actuation of identical helical micromachines
2017
GUIDELINES FOR LIMITING EXPOSURE TO TIME-VARYING ELECTRIC AND MAGNETIC FIELDS (1 Hz TO 100 kHz)
2010 Standout
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
2012 Standout
UV Radiation and the Skin
2013 Standout
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma
2016

Works of Etsuo Kunieda being referenced

Acceptable Toxicity After Stereotactic Body Radiation Therapy for Liver Tumors Adjacent to the Central Biliary System
2012
Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients
2013
Biodistribution of immunoliposome labeled with Tc-99m in tumor xenografted mice
2009
Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing
2008
Neurocognitive Function of Patients with Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone
2007
Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose–volume histograms
2004
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)
2011
Scintigraphic evaluation of myocardial ischaemia using a new fatty acid analogue: iodine-123-labelled 15-( p -iodophenyl)-9-( R , S )-methylpentadecanoic acid (9MPA)
1999
Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
2015
Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma
2012
Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity
2007
Possible Misinterpretation of Demarcated Solid Patterns of Radiation Fibrosis on CT Scans as Tumor Recurrence in Patients Receiving Hypofractionated Stereotactic Radiotherapy for Lung Cancer
2007
Threshold Doses for Focal Liver Reaction After Stereotactic Ablative Body Radiation Therapy for Small Hepatocellular Carcinoma Depend on Liver Function: Evaluation on Magnetic Resonance Imaging With Gd-EOB-DTPA
2014
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function
2010
Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose 125I seeds
2011
Interinstitutional Variations in Planning for Stereotactic Body Radiation Therapy for Lung Cancer
2007
Development of realistic high-resolution whole-body voxel models of Japanese adult males and females of average height and weight, and application of models to radio-frequency electromagnetic-field dosimetry
2003 Standout
Bronchial arteries: CT demonstration with arteriographic correlation.
1987
Tumor Response on CT Following Hypofractionated Stereotactic Ablative Body Radiotherapy for Small Hypervascular Hepatocellular Carcinoma With Cirrhosis
2013
Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma
2014
Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma
2013
Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation
2016
Radiation Injury After Hypofractionated Stereotactic Radiotherapy for Peripheral Small Lung Tumors: Serial Changes on CT
2004
Rankless by CCL
2026